Asana Medical, Inc. to Present at 2015 BIO International Convention June 15th – 18th
Miami Lakes, FL – June 1, 2015 – Asana Medical, Inc., (“Asana”, the “Company”) an emerging medical device company focused on the development and commercialization of its innovative tissue-engineered therapy to treat Inflammatory Bowel Disease (“IBD”), is pleased to announce that it will be participating as an exhibitor and presenter at the 2015 BIO International Convention being held in Philadelphia, PA. June 15th – 18th.
“We are looking forward to attending the BIO International Convention and to be able to present our medical device technology to some of the world’s most influential and knowledgeable biotech experts and investors,” stated Marc Ramer, CEO of Asana Medical, Inc.
Mr. Ramer is scheduled to present at 11:40 am on June 16th in the Empire State Theatre located at the New York Bio Pavilion, Booth #3949.
Asana’s lead product “ECMH” is being initially developed to treat ulcerative colitis, one major form of IBD. Future generations of Asana’s product will be applied to Crohn’s Disease, the other major form of IBD, and possibly to other gastrointestinal conditions. ECMH is a hydrogel composed of porcine extracellular matrix, which will be delivered to the diseased colon to build a protective barrier and create a scaffold for natural tissue recovery to occur. Extracellular matrix (ECM) products have demonstrated excellent safety and efficacy in multiple clinical applications, including esophageal repair, hernia repair, pericardial closures, and burn and wound treatments. It has been successfully commercialized for over a decade. Asana’s ECMH technology offers the promise of a non-pharmacologic, non-surgical treatment for UC.
If you are unable to visit with the Company during the 2015 BIO Convention, stay informed on all Asana Medical, Inc. developments and news by joining our social communities on Facebook and Twitter and sign up for our email alerts.
ABOUT 2015 BIO INTERNATIONAL CONVENTION
Billed as the largest global event for the biotechnology industry, the 2015 BIO International Convention is organized by the Biotechnology Industry Organization. The organization represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. 2015 BIO covers the wide spectrum of life science innovations and application areas. Drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy are just a few of the industries represented. Thousands of leaders from over 65 countries are expected to attend 2015 BIO. The key elements of the event are education, networking, BIO Business Forum partnering and the 1,700 companies showcasing the latest technologies, products and services in the BIO Exhibition. For more information, visit http://convention.bio.org/2015/.
ABOUT ASANA MEDICAL, INC.
Asana Medical, Inc. is a regenerative medicine company developing a tissue engineered therapy for the treatment of Ulcerative Colitis (UC). The Company’s product ECMH, a novel application of a proven technology, will be a first-in-class therapy for patients suffering from Ulcerative Colitis. This therapy will be positioned to compete in a multi-billion-dollar market dominated by biologic and drug therapies that can have significant side effects. Additionally, 20-30% of patients do not benefit from these therapies and have no alternative except colon removal surgery. Asana has an experienced management team, strong patent protection, world-class advisors in business and medicine, and compelling preclinical proof-of-concept data. For more information, visit www.asanamedical.com.
Executive Vice President
Asana Medical, Inc.
6135 NW 167 Street, Suite E15
Miami Lakes, FL 33015
Tel: (844) 432-7262 Ext 102